Association between drugs and vaccines commonly prescribed to older people and bullous pemphigoid: a case–control study
Mikolaj Swiderski(University of Nottingham), Sonia Gran(University of Nottingham), Carron Layfield(University of Nottingham), Rowan Harwood(University of Nottingham), Vibhore Prasad(University of Nottingham), Grazziela P. Figueredo(University of Nottingham), Yana Vinogradova(University of Nottingham), Roger Knaggs(University of Nottingham), Karen Harman(University Hospitals of Leicester NHS Trust), Monica S M Persson(University of Nottingham)
Cited by 6
Related Papers
Consensus statement on definitions of disease, end points, and therapeutic response for pemphigus
|Journal of the American Academy of Dermatology|2008|586
Development and initial testing of a new instrument to measure the experience of eczema control in adults and children: Recap of atopic eczema ( <scp>RECAP</scp> )
|British Journal of Dermatology|2019|103
Incidence, prevalence and mortality of bullous pemphigoid in England 1998–2017: a population‐based cohort study*
|British Journal of Dermatology|2020|98
The global incidence of bullous pemphigoid: a systematic review and meta‐analysis
|British Journal of Dermatology|2021|72
A 10‐year review of surgical management of dermatofibrosarcoma protuberans*
|British Journal of Dermatology|2020|65